经尿道等离子体电汽化切除术治疗高危型前列腺增生43例

Transurethral plasmakentic electrovaporization resection of prostate for high risk patients with BPH

目的:探讨经尿道等离子体电汽化切除术对高危型前列腺增生患者的疗效和安全性。方法:采用等离子体电汽化切除术治疗4 3例高危型前列腺增生患者,并对这些患者的术前、术中及术后一系列生理、生化指标进行记录比较。结果:手术时间为(48 2±19 2 )min ,术中出血量为(36±6 8)mL ,术后膀胱冲洗时间为(16 3±8 5 )h ,拔除尿管天数为(3 1±1 3)d ,无明显电解质及血糖波动,术后住院时间为(5 5±2 6 )d ;国际前列腺症状评分(IPSS)从30 9±3 2下降到7 3±3 2 ,最大尿流率(Qmax)从(3 7±3 2 )mL·s- 1上升到(2 0 5±4 3)mL·s- 1;生活质量评分(QOL)从5 1±0 6下降到1 4±0 8,未发生严重的并发症。结论:经尿道前列腺等离子体电汽化切除术对高龄高危型患者安全性高、并发症少、疗效好。

Aim:To study the efficacy and safety of transurethral plasmakentic electrovaporization resectiion (TUPKEP) for high risk patients with BPH (benign prostatic hyperplasia, BPH). Methods: Forty-three BPH patients at high risk were treated by TUPKEP, and physiological and biochemical indexes were treated by TUPKEP, and physiological and biochemical indexes were recorded and compared perioperatively. Results: The intraoperative blood loss was (136±68) mL, operating time (48.2±19.2) min, postoperative bladder washout (BW) and catheterization time was (16.5±8.5) h and (3.1±1.3) d. No electrolyte, blood gluose disturbance happened. Postoperative hospitalization time was (5.5±2.6) d, IPSS dropped from 30.9±3.2 to 7.3±3.2, Qmax increased from 3.7±3.2 to 20.5±4.3, QOL decreased from 5.1±0.6 to 1.4±0.8. Conclusion:TUPKEP is very effective and safe for aged patients with BPH at high risk. However, further studies must be warranted.